David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
As one of the most massive and successful business sectors, the pharmaceutical industry is a potent force for good in the community, yet its behaviour is frequently questioned: could it serve society at large better than it has done in the recent past? Its own internal ethics, both in business and science, may need a careful reappraisal, as may the extent to which the law - administrative, civil and criminal - succeeds in guiding (and where neccessary contraining) it. The rules of behavior that may be considered to apply to today's pharmaceutical industry have emerged over a very long period and the process goes on. Even the immensely detailed standards for quality, safety and efficacy laid down in drug law and regulation during the second half of the twentieth century have their limitations as tools for ensuring that the public interest is well served. In particular, national and regional regulatory agencies are heavily dependent on industrial data for their decision-making, their standards and competence vary, and even the existing network of agencies does not cover the entire world. What is more there are many areas of law and regulation affecting the industry, concerning for example the pricing of medicines, the conduct of clinical studies, the health protection of workers and concern for the environment. In some fields it is indeed hardly possible to maintain standards through regulation. Professor N.M. Graham Dukes, a physician and lawyer with long term experience in industrial research management, academic study and international drug policy, provides here a powerfully documented analysis into the way this industry thinks, acts, and is viewed, and examines the current trends pointing to change. *Provides a balanced picture of the current role of the pharmaceutical industry in society *Includes indices of conventions, laws, and regulations; as well as judicial and disciplinary cases *This is the only book addressing the legal implications of big pharma activities and ethical standards
|Keywords||Drugs Law and legislation Pharmaceutical industry Moral and ethical aspects Pharmaceutical industry Standards|
|Categories||categorize this paper)|
|Buy the book||$139.44 used (27% off) $139.48 new (27% off) $172.49 direct from Amazon (10% off) Amazon page|
|Call number||K3636.D853 2005|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Henry Adobor (2012). Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry. [REVIEW] Journal of Business Ethics 105 (2):239-255.
Rusla Anne Springer (2011). Pharmaceutical Industry Discursives and the Marketization of Nursing Work: A Case Example. Nursing Philosophy 12 (3):214-228.
Similar books and articles
Shaili Jain (2007). Understanding Physician-Pharmaceutical Industry Interactions. Cambridge University Press.
Richard T. de George (2005). Intellectual Property and Pharmaceutical Drugs. Business Ethics Quarterly 15 (4):549-575.
Joao Calinas-Correia (2013). Big Pharma: A Story of Success in a Market Economy. [REVIEW] Medicine, Health Care and Philosophy 16 (2):305-309.
Edward R. Balotsky (2009). Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries. [REVIEW] Journal of Business Ethics 84 (1):75 - 88.
Włodzimierz Kubiak (2005). Medicine and Pharmacy — Facts and Myths About the Development of an Innovative Pharmaceutical Industry in Poland. Science and Engineering Ethics 11 (1):41-51.
Steven C. Schachter (ed.) (2008). Managing Relationships with Industry: A Physician's Compliance Manual. Elsevier.
David Finegold (ed.) (2005). Bioindustry Ethics. Elsevier Academic Press.
David Badcott (2013). Big Pharma: A Former Insider's View. [REVIEW] Medicine, Health Care and Philosophy 16 (2):249-264.
Marc A. Rodwin (2011). Reforming Pharmaceutical Industry-Physician Financial Relationships: Lessons From the United States, France, and Japan. Journal of Law, Medicine and Ethics 39 (4):662-670.
Sue Eckstein (ed.) (2003). Manual for Research Ethics Committees. Cambridge University Press.
Marcia M. Boumil, Emily S. Cutrell, Kathleen E. Lowney & Harris A. Berman (2012). Pharmaceutical Speakers' Bureaus, Academic Freedom, and the Management of Promotional Speaking at Academic Medical Centers. Journal of Law, Medicine and Ethics 40 (2):311-325.
Joakim Sandberg (2010). Ethics and the Pharmaceutical Industry. [REVIEW] European Journal of Health Law 17:211-214.
Added to index2011-06-02
Total downloads12 ( #126,914 of 1,099,004 )
Recent downloads (6 months)4 ( #80,012 of 1,099,004 )
How can I increase my downloads?